Cardiac Dysautonomia Predicts Long-Term Survival in Hereditary Transthyretin Amyloidosis After Liver Transplantation-Reference-Cited by-同舟云学术

Cardiac Dysautonomia Predicts Long-Term Survival in Hereditary Transthyretin Amyloidosis After Liver Transplantation

Published:2016-12 Issue:12 Volume:9 Page:1432-1441
ISSN:1936-878X
Container-title:JACC: Cardiovascular Imaging
language:en
Short-container-title:JACC: Cardiovascular Imaging

Author:

Algalarrondo Vincent,Antonini Teresa,Théaudin Marie,Chemla Denis,Benmalek Anouar,Lacroix Catherine,Castaing Denis,Cauquil Cécile,Dinanian Sylvie,Eliahou Ludivine,Samuel Didier,Adams David,Le Guludec Dominique,Slama Michel S.,Rouzet François

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Reference36 articles.

1. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis: a position statement from the ESC Working Group on Myocardial and Pericardial Diseases;Rapezzi;Eur Heart J,2013

2. Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective;Rapezzi;Eur Heart J,2013

3. Diagnosis, prognosis, and therapy of transthyretin amyloidosis;Gertz;J Am Coll Cardiol,2015

4. Myocardial muscarinic receptor upregulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy;Delahaye;Circulation,2001

5. Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability;Delahaye;Eur J Nucl Med,1999

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiopulmonary Exercise Testing in Evaluating Transthyretin Amyloidosis;JAMA Cardiology;2024-04-01

2. Characterization of the G-quadruplexes in the transthyretin gene and its role in silencing transthyretin mRNA transcription;Bioorganic & Medicinal Chemistry Letters;2024-01

3. Hereditary transthyretin amyloidosis in the era of RNA interference, antisense oligonucleotide, and CRISPR-Cas9 treatments;Blood;2023-11-09

4. Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers;Journal of Neurology, Neurosurgery & Psychiatry;2023-10-24

5. Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis;Heart;2023-07-06